瑞士药企罗氏将在美国投资500亿美元,以避免特朗普的关税

美港电讯
22 Apr

【瑞士药企罗氏将在美国投资500亿美元,以避免特朗普的关税】金十数据4月22日讯,总部位于瑞士巴塞尔的跨国医药研发生产商罗氏周二表示,未来五年将在美国投资500亿美元,创造超过1.2万个新工作岗位,这是全球企业对特朗普关税政策做出反应的最新大规模投资。瑞士制药商诺华制药本月早些时候表示,将在美国投资230亿美元,而礼来和强生最近也宣布了大规模投资。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10